← All trials
NCT02317198
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2013
- Primary completion
- Jan 1, 2018
- Completion date
- Jan 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- St. Antonius Hospital, NieuwegeinLead sponsor
- Gelre HospitalsCollaborator
- Meander Medical CenterCollaborator
- Gelderse Vallei HospitalCollaborator
- Rijnstate HospitalCollaborator
- Noordwest ZiekenhuisgroepCollaborator
- Medical Center LeeuwardenCollaborator
- Leiden UniversityCollaborator
- Utrecht UniversityCollaborator
- Isala Clinics, Zwolle, The NetherlandsCollaborator
- St. Antonius Hospital, NieuwegeinOverall official - principal investigator
- St. Antonius Hospital, NieuwegeinReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.